Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 50 years old or older
- You have given your written agreement (consent) to take part in the study
- You are covered by a social insurance or health coverage scheme
- You have been diagnosed with giant cell arteritis (a condition causing inflammation of blood vessel walls) based on recognised 2022 medical guidelines
- Your diagnosis has been confirmed using MRI (a type of body scan) and ultrasound
Who may not be able to join:
- You are unable to have an MRI scan for any reason, such as having certain metal implants in your body or experiencing severe claustrophobia (fear of enclosed spaces)
- You have a known allergy or sensitivity to gadobutrol, which is a contrast dye sometimes used during MRI scans
- You are currently under legal protection or guardianship (confirm with trial site)
- You are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0148036454
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Describe the evolution over time of angiographic-MRI abnormalities at 1 month, 3 months, 6 and 12 months from the diagnosis of Horton's disease.; Describe the evolution over time of ultrasound abnormalities at 1 month, 3 months, 6 and 12 months from the diagnosis of Horton's disease.; Describe the evolution over time of ultrasound abnormalities at 1 month, 3 months, 6 and 12 months from the diagnosis of Horton's disease.; Describe the evolution over time of ultrasound abnormalities at 1 month, 3 months, 6 and 12 months from the diagnosis of Horton's disease.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.